- 全部删除
 
您的购物车当前为空
Troriluzole 是一种具有口服活性谷氨酸调节剂,具有抗癌活性。Troriluzole 可提高位于神经胶质细胞的兴奋性氨基酸转运体的表达,可用于研究脊髓小脑性共济失调、阿尔茨海默病和广泛性焦虑症 (GAD) 。

Troriluzole 是一种具有口服活性谷氨酸调节剂,具有抗癌活性。Troriluzole 可提高位于神经胶质细胞的兴奋性氨基酸转运体的表达,可用于研究脊髓小脑性共济失调、阿尔茨海默病和广泛性焦虑症 (GAD) 。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 993  | In stock | |
| 5 mg | ¥ 2,360  | In stock | |
| 10 mg | ¥ 3,730  | In stock | |
| 25 mg | ¥ 5,930  | In stock | |
| 50 mg | ¥ 7,850  | In stock | |
| 100 mg | ¥ 10,800  | In stock | |
| 200 mg | ¥ 14,500  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,180  | In stock | 
Troriluzole 相关产品
| 产品描述 | Troriluzole is an orally active glutamate modulator with anticancer activity.Troriluzole enhances the expression of excitatory amino acid transporters located in glial cells and is used in the study of spinocerebellar ataxia, Alzheimer's disease, and generalized anxiety disorder (GAD).  | 
| 体外活性 | Troriluzole 是 EAAT2 调节剂、NMDA receptor 拮抗剂以及 Nav1.5 阻滞剂,常用于强迫症等神经系统疾病研究[1]。  | 
| 别名 | FC 4157, BHV-4157a, BHV-4157, BHV4157, BHV 4157 | 
| 分子量 | 419.38 | 
| 分子式 | C15H16F3N5O4S | 
| CAS No. | 1926203-09-9 | 
| Smiles | CN(CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)C(=O)CNC(=O)CN | 
| 密度 | 1.518 g/cm3 (Predicted) | 
| Sequence | H-Gly-Gly-Sar-Unk | 
| Sequence Short | GGG | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 30 mg/mL (71.53 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.77 mM), Sonication is recommended.  请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表  | |||||||||||||||||||||||||||||||
DMSO 
  | |||||||||||||||||||||||||||||||
评论内容